WXWenxuan Xiang

Wenxuan Xiang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Wenxuan Xiang has a total of 12 co-authors. Here are the top co-authors by number of shared publications:

  • Dan Yang

    Department of Computational Biology and Bioinformatics, Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100193, China

    2 shared publications
  • Xiangyu Xian

    State Key Laboratory of Respiratory Health and Multimorbidity, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing. (Q.C., X.W., Z.Y., S.L., T.C., Y.Z., X.X., T.Z., J.W.)

    2 shared publications
  • Xiaohong Song

    Department of Vascular Surgery, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China

    2 shared publications
  • Yuehong Zheng

    Department of Vascular Surgery Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College Beijing China

    2 shared publications
  • Chuxiang Lei

    Department of Vascular Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Dongcheng District, Beijing, China

    1 shared publication
  • Haoxuan Kan

    Department of Vascular Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Dongcheng District, Beijing, China

    1 shared publication

Latest Publications

  • Open Access

    FAM3A drives uncoupling of muscle lipid accumulation and insulin resistance depending on insulin receptor

    by Dan Yang, Xiaohong Song, Xu Zeng, Zenghan Cao, Wenxuan Xiang, Xiangyu Xian, Lichai Yuan, Zheng Zhang, Yuehong Zheng

    Obesity-associated insulin resistance (IR) is closely related to intramyocellular lipid accumulation in skeletal muscle. FAM3 metabolism regulating signaling molecule A (FAM3A) is expressed and secreted in almost all tissues. However, its biological roles and underlying mechanisms remain largely unknown. Here, we reported that abnormal lipid metabolism decreased the FAM3A level. To investigate the function of FAM3A, a transgenic mouse strain was generated, in which FAM3A protein was overexpressed systemically. Proteomic analyses revealed that proteins related to lipid metabolic processes, specifically fatty acid (FA) synthesis complex enzymes and adiponectin were upregulated in the skeletal muscles of the FAM3A-transgenic mice compared with those in the skeletal muscles of the wild-type control mice. Furthermore, a positive correlation between FAM3A and adiponectin levels was observed in patient plasma samples. FAM3A transgene or FAM3A injection in high-fat diet (HFD)-fed mice led to increased levels of muscular srebp1, fas, acc, and acly expression, De novo FA biosynthesis, and lipid accumulation compared with those in matched controls. However, FAM3A transgene or FAM3A injection suppressed IR and inflammation and promoted glucose consumption in HFD-fed mice. Moreover, these functions of FAM3A were attenuated by the inhibition of PPARα. Notably, the inhibition of the insulin receptor abolished the linkage of FAM3A and PPARα as well as their downstream metabolic effects. Taken together, these findings suggest that increasing FAM3A expression in the body may represent a unique opportunity to avoid IR in individuals with obesity induced by high lipid levels.


  • Open Access

    FAM3A reshapes VSMC fate specification in abdominal aortic aneurysm by regulating KLF4 ubiquitination

    by Chuxiang Lei, Haoxuan Kan, Xiangyu Xian, Wenlin Chen, Wenxuan Xiang, Xiaohong Song, Jianqiang Wu, Dan Yang, Yuehong Zheng

    Reprogramming of vascular smooth muscle cell (VSMC) differentiation plays an essential role in abdominal aortic aneurysm (AAA). However, the underlying mechanisms are still unclear. We explore the expression of FAM3A, a newly identified metabolic cytokine, and whether and how FAM3A regulates VSMC differentiation in AAA. We discover that FAM3A is decreased in the aortas and plasma in AAA patients and murine models. Overexpression or supplementation of FAM3A significantly attenuate the AAA formation, manifested by maintenance of the well-differentiated VSMC status and inhibition of VSMC transformation toward macrophage-, chondrocyte-, osteogenic-, mesenchymal-, and fibroblast-like cell subpopulations. Importantly, FAM3A induces KLF4 ubiquitination and reduces its phosphorylation and nuclear localization. Here, we report FAM3A as a VSMC fate-shaping regulator in AAA and reveal the underlying mechanism associated with KLF4 ubiquitination and stability, which may lead to the development of strategies based on FAM3A to restore VSMC homeostasis in AAA.